The DNA damage response is essential to maintain genomic stability, suppress replication stress, and protect against carcinogenesis. The ATR-CHK1 pathway is an essential component of this response, which regulates cell cycle progression in the face of replication stress. PARP14 is an ADP-ribosyltransferase with multiple roles in transcription, signaling, and DNA repair. To understand the biological functions of PARP14, we catalogued the genetic components that impact cellular viability upon loss of PARP14 by performing an unbiased, comprehensive, genome-wide CRISPR knockout genetic screen in PARP14-deficient cells. We uncovered the ATR-CHK1 pathway as essential for viability of PARP14-deficient cells, and identified regulation of DNA replication dynamics as an important mechanistic contributor to the synthetic lethality observed. Our work shows that PARP14 is an important modulator of the response to ATR-CHK1 pathway inhibitors.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367200 | PMC |
| http://dx.doi.org/10.1093/nar/gkaa508 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Molecular mechanisms restoring olaparib efficacy through ATR/CHK1 pathway inhibition in olaparib-resistant BRCA1/2 ovarian cancer models.
Biochim Biophys Acta Mol Basis Dis
February 2025
Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska Street, 90-236 Lodz, Poland. Electronic address:
Article Synopsis
- Olaparib resistance in ovarian cancer patients calls for new strategies, leading to the creation of a patient-derived xenograft model to study this issue.
- In experiments, olaparib-resistant tumors were treated with olaparib alone, or combined with ATR and CHK1 inhibitors, revealing that these combinations effectively hindered tumor growth and altered key molecular signaling pathways.
- The study enhances our understanding of how to combat olaparib resistance in high-grade serous ovarian cancer with BRCA1/2 mutations, suggesting that targeting the ATR/CHK1 pathways could improve treatment outcomes for patients who are initially unresponsive to olaparib.
Advancing cancer therapy: new frontiers in targeting DNA damage response.
Front Pharmacol
September 2024
Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Article Synopsis
- * Targeted therapies, like PARP inhibitors, have shown promise in treating cancers with specific DDR defects, such as mutations in BRCA1 or BRCA2, by taking advantage of vulnerabilities through synthetic lethality.
- * Ongoing research aims to identify new DDR therapeutic targets and improve treatment strategies by optimizing therapies, understanding resistance mechanisms, and combining them with other treatment modalities.
Base-excision repair pathway regulates transcription-replication conflicts in pancreatic ductal adenocarcinoma.
Cell Rep
October 2024
Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA; Department of Cancer Genetic & Epigenetics, City of Hope National Medical Center, Duarte, CA, USA. Electronic address:
Article Synopsis
- Oncogenic mutations like those in KRAS cause transcription-replication conflicts (TRCs) in pancreatic ductal adenocarcinoma (PDAC), making them more common in these cancer cells than in other tumors or normal cells.
- The study identifies base-excision repair (BER) factors as key regulators of TRCs, with BER inhibitors increasing TRCs by disrupting RNA polymerase II and R-loop dynamics.
- Combining ATR and BER inhibitors shows promise in enhancing DNA damage and reducing PDAC cell growth, emphasizing the therapeutic potential of targeting these pathways in cancer treatment.
Cigarette smoke extract induces malignant transformation and DNA damage via c-MET phosphorylation in human bronchial epithelial cells.
Ecotoxicol Environ Saf
September 2024
School of Public Health, North Sichuan Medical College, Nanchong 637000, China. Electronic address:
Cigarette smoke, a complex mixture produced by tobacco combustion, contains a variety of carcinogens and can trigger DNA damage. Overactivation of c-MET, a receptor tyrosine kinase, may cause cancer and cellular DNA damage, but the underlying mechanisms are unknown. In this work, we investigated the mechanisms of cigarette smoke extract (CSE) induced malignant transformation and DNA damage in human bronchial epithelial cells (BEAS-2B).
View Article and Find Full Text PDFCorrection to: Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
Cell Biol Toxicol
August 2024
Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Via Piero Maroncelli, 40, 47014, Meldola, FC, Italy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!